Based on the sources provided, here is the reproduction of the article regarding the challenges faced by stock investors in the current market.
‘Needle hunting’ starts pricking stock investors
MARKET REALITY. Winners still exist, but the odds changed, with only 26% beating the Nifty 500 TRI in the last one year period
By Kumar Shankar Roy
Index fund pioneer John Bogle’s famous line about buying the haystack, instead of hunting for the needle, feels like a cliché in bull markets. But in the last 12 months or so, stock investors searching for the needle felt the prick as the odds flipped in Dalal Street. Sure the benchmark Nifty 500 TRI rose a respectable 12.57 per cent. Yet, only 26 per cent of stocks beat it, with just 39 per cent churning out a positive gain, and the average stock return slipping into negative territory for the first time in at least half a decade.
A study of all NSE-listed stocks in a fixed universe of 1,494 names across 5-yearly blocks shows how investing in stocks has become unforgiving in recent times. Contrast this to the 2021 period when stock picking looked like a "hobby between lunch and a broking app login". Seven in ten stocks beat the index in that period, and over eight in ten stocks clocked positive returns. Those were times an investor could be directionally right without being particularly precise.
Fast forward to the twelve months ended February 13, 2026, and underperformance has gone mainstream. Excitement got expensive as investors went down the market capitalisation ladder.
- Large-caps: 60 per cent of scrips, including RIL, Bharti Airtel, and SBI, beat the Nifty 500 TRI.
- Mid-caps: The hit rate fell to 50 per cent from 68 per cent in the previous year, though stocks like Marico, HPCL, BHEL, and Aditya Birla Capital still outperformed.
- Small-caps: This segment turned into a "veritable graveyard," with only 20.5 per cent of stocks beating the benchmark.
Multi-baggers have thinned out sharply, and most stocks now cluster in modest-return or loss buckets. Today’s market brings richer valuations, tighter global liquidity, FPI outflows, a weaker rupee, and fresh AI anxiety for sectors like tech services.
SHRINKING BREADTH
The hit rate for beating the Nifty 500 TRI has plunged from 69 per cent (Feb 2021–Feb 2022) to just 26 per cent in the latest twelve-month period. Similarly, the percentage of stocks in the black has dropped from 90 per cent in the year to February 2023 to only 39 per cent in the year to February 2026. While the index remains up, individual stock portfolios often feel like they belong among the worst-performing markets globally.
The sector split highlights these challenges:
- IT-software: Only 11 per cent of stocks outperformed the index; none of the top 10 (like TCS or Infosys) beat it.
- Chemicals & Textiles: Hit rates were near 12 per cent and less than 10 per cent, respectively.
- Banks & Auto Ancillaries: These remained pockets of strength, with benchmark-beating rates of 70.6 per cent and 54.4 per cent, respectively.
KNOW YOUR EDGE
When market breadth shrinks, big winners often merely "decorate social media" rather than rescue entire portfolios. Former PIMCO CEO Mohamed El Erian offers retail traders a blunt test: If you cannot explain your edge over the crowd, you are not buying a stock; you are buying a lottery ticket.
In this environment, Bogle’s "haystack logic" stops sounding boring. Preferring the index over an individual stock where you have not performed due diligence is not laziness—it is arithmetic.
Based on the sources provided, here is the reproduction of the article regarding the challenges faced by stock investors in the current market.
Based on the sources provided, here is the reproduction of the article regarding the role and performance of Multi-Asset Allocation Funds (MAAFs).
Balance beats bravado when cycles turn
ALL WEATHER. We address two key questions — Where do all-in-one Multi-Asset Allocation Funds fit in diversified portfolios, and which one suits your goals and risk profile?
By Dhuraivel Gunasekaran, bl. research bureau
While Indian equity markets swung between peaks and troughs over the past two years, gold and silver glittered and scaled record highs. One mutual fund category, Multi-Asset Allocation Funds (MAAFs), turned this divergence to its advantage, delivering a compelling 16 per cent CAGR during this period. This outperformed hybrid peers, market-cap-oriented equity funds, and broader benchmarks, attracting nearly ₹93,000 crore in net inflows over two years.
WHAT ARE MAAFs?
MAAFs are hybrid mutual funds that invest in at least three asset classes—typically equities, debt, and commodities—with a minimum 10 per cent allocation to each. Currently, 44 schemes operate under this mandate, though they follow widely differing asset-allocation strategies and risk profiles. Following regulatory changes in February 2025, these funds are broadly classified into three categories:
- Active MAAFs: Rely on dynamic, model, and manager-driven tactical allocation.
- Multi-Asset Passive FoFs: Invest in a basket of passive index funds and ETFs across asset classes.
- Multi-Asset Omni FoFs: Combine both passive and active fund structures.
PERFORMANCE AND RESILIENCE
To evaluate their core capability, it is useful to look at performance before the precious metals rally. Between June 2018 and June 2024, MAAFs with over 65 per cent equity exposure delivered an average CAGR of 18 per cent, matching the Nifty 50 Total Return Index.
MAAFs have also shown significant resilience during downturns.
- 2020 Covid Crash: These funds declined by an average of 26 per cent, while the Nifty 50 TRI fell by 38 per cent.
- September 2024–March 2025 Correction: They fell around 8 per cent, compared to a 15 per cent decline in the index.
TAXATION AND SUITABILITY
From a taxation perspective, MAAFs fall into two buckets:
- Active MAAFs (65%+ domestic equities): Qualify for equity taxation (20% short-term, 12.5% long-term capital gains).
- Sub-65% Equity/FoFs: Taxed as "other-than-specified" schemes, where short-term gains (under 24 months) are taxed at slab rates, and long-term gains are taxed at 12.5% without indexation.
WHAT SHOULD INVESTORS DO?
For investors who lack the time or discipline to rebalance their own portfolios, a MAAF serves as a convenient core holding. However, a wrong choice can distort a portfolio's risk profile.
- Investors seeking equity-like returns: Should consider 65%+ equity MAAFs such as those from ICICI Prudential, quant, and HDFC.
- Investors seeking downside cushioning: May prefer sub-65% equity options like Nippon India, SBI, and UTI Multi Asset Allocation Funds.
As hedge fund legend Ray Dalio noted, "You should have a strategic asset allocation mix that assumes that you don't know what the future is going to hold".
Based on the sources provided, here is the reproduction of the article regarding the new Consumer Price Index (CPI) series and its impact on financial planning.
CPI new series & your retirement math
MONEY WISE. CPI 2024 is a better mirror of today’s spending and today’s price world. It changes the measuring tape, not the actual prices or your interest rate.
By Kumar Shankar Roy, bl. research bureau
In a dialogue between two colleagues, Sanket and Suman, the implications of the government’s decision to rebuild the Consumer Price Index (CPI) are decoded. The government has updated the shopping basket and reset the baseline year from 2012 to 2024.
Understanding the Change
CPI acts as a monthly household bill scorecard, tracking the cost of a fixed basket of common goods and services. The base year serves as a starting ruler set at 100; for instance, the CPI general for January 2026 stood at 104.46 compared to 101.67 in January 2025, implying a 2.75 per cent inflation rate.
The base was updated because spending habits have shifted significantly since 2012, with more emphasis on services and digital purchases. This update utilized the 2023-24 Household Consumption Expenditure Survey (HCES) to capture modern spending across rural and urban India.
Expanded Tracking and Collection
The new series, CPI 2024, has significantly expanded its reach:
- Market Coverage: It covers 1,465 rural markets and 1,395 urban markets across 434 towns.
- E-commerce: It adds 12 online markets in 12 major cities to capture digital prices.
- Modernization: Price collection has moved from paper to tablets using Computer Assisted Personal Interviewing (CAPI).
- New Inclusions: For the first time, rural house rent is included in the index.
Impact on Investors and Retirement
For retail investors, the new series affects how inflation is read, how real returns are computed, and how long-range planning is conducted.
Real return is what remains from earnings after subtracting inflation. If a Fixed Deposit (FD) offers a 7 per cent nominal interest and inflation is 3 per cent, the real return is 4 per cent. In retirement planning, even a small shift in assumed inflation changes the required corpus, equity allocation comfort, and the sustainable withdrawal path.
Suman suggests using CPI as a general guide but warns that households often face higher personal inflation in health and education than the headline figure. Therefore, separate assumptions should be maintained for these major expenses.
Shifting Basket Weights
The weightage of items within the basket has changed:
- Food: Has become less dominant than before.
- Services: Housing, transport, health, communication, and personal services have gained importance.
- Sensitivity: Because food weight is lower, a spike in food prices has slightly less pull on the overall headline inflation than it once did.
For example, in January 2026, while silver jewellery jumped 159.67 per cent and tomatoes rose 64.80 per cent, these spikes had a limited impact on the headline number because their individual CPI weights are small.
Practical Takeaways
- Update Spreadsheets: Investors should transition to using CPI 2024 for tracking current inflation.
- Use Inflation Ranges: Instead of a single number, use a range for financial goals and stress test plans for higher inflation scenarios, particularly for healthcare.
- Indirect Effects: While the new CPI doesn't mechanically change interest rates or taxes, it influences market expectations, bond yields, and policy decisions over time.
Based on the sources provided, here is the reproduction of the article regarding the Reserve Bank of India’s (RBI) likely policy path through 2026.
‘RBI likely to be on a pause through 2026’
EXPERT TALK. No need for the RBI to give further growth impulse, says Axis MF’s Head of Fixed Income Devang Shah
By Lokeshwarri SK
In an exclusive interaction with businessline, Devang Shah, Head-Fixed Income, Axis Mutual Fund, discusses RBI’s policy rate action, demand-supply dynamics in the G-sec market, and the way forward for fixed-income investors.
The Current Rate Cycle
The RBI cut 125 basis points between February and December last year. Do you think that the current rate cycle has come to an end?
As you rightly summed up, RBI has taken a lot of monetary policy action in the last 12 months and they have been very supportive to the growth agenda. We also need to keep in mind that there has been more than ₹18-lakh crore of liquidity infusion in the last 12 months through various actions like OMOs, CRR cuts, and FX swaps.
The Budget has been quite supportive for growth, with a significant increase in spending on capital investment and major schemes. Therefore, the RBI need not worry about giving any further growth impulse. Additionally, the trade deal with the US is good news; without it, growth in the second half of 2026 could have been weaker.
We believe that growth can be in the 6.75 to 7 per cent band for FY27. While there may be an uptick in inflation in the second half of the year, it is not expected to exceed 4.75 per cent for the full year. In this context, I think RBI can stay on a pause for most of this year. A rate increase in the second half of the year would only be considered if there is a bad monsoon or a significant inflation spike, though I assign a very low probability to that.
Market Borrowing and Yields
What is your view on the gross market borrowing of ₹17.2-lakh crore in the Budget? Does the market have the capability to absorb the supply?
The Budget numbers seem quite conservative regarding tax revenue and nominal GDP. However, the gross borrowing of ₹17.25-lakh crore is slightly higher than our estimates of ₹16.5 to ₹16.75-lakh crore. We believe there is a demand-supply gap of close to ₹2–2.5-lakh crore, even after assuming ₹4–5-lakh crore of OMOs by the RBI. The inclusion of Indian bonds in the Bloomberg active global aggregator index could help bridge this gap by fetching roughly $25 billion of flows.
What is the range that the 10-year bond yield can move in the next year or so?
We see the 10-year yield in the 6.60–6.80 band from January to March 2026. If the RBI disappoints on OMOs, yields might inch up toward 6.80–7 per cent from April onwards. For the full year, the band will likely stay between 6.75 to 7 for the most part.
Global Context and Investor Advice
What is your view on global bond yields? Does the hardening of US yields affect domestic yields as well?
The correlation is to a large extent broken between US bonds and Indian bonds. For instance, since 2022, US treasury yields rose from 2 per cent to 4.25 per cent, while Indian 10-year yields actually fell from 7.5 per cent to 6.75 per cent. Global central bankers are likely on a pause now after significant rate easing over the last 12–18 months.
What is your advice for fixed-income investors?
In 2026, the RBI will be on a pause for the most part of the year. It will be good for investors to stick to the short end of the curve and buy 1–2-year AAA corporate bonds, which are available at significantly higher yields.
Retail investors can also look at gilt funds with higher allocations to State government securities, as there is a significant rise in spreads for State development loans. For medium-term investors (up to two years), income plus arbitrage fund of funds is a very good category, as they are taxed like equity funds if you stay invested for two years.
PROFILE: Devang Shah Devang Shah, Head of Fixed Income at Axis Mutual Fund, joined Axis AMC in 2012. With over 20 years of industry experience, he manages fixed-income strategies with a focus on risk and yield optimization.
Based on the sources provided, here is the reproduction of the article regarding Sun Pharma’s performance and outlook.
Betting on launched assets and pipeline
PHARMACEUTICALS. New launches, strong portfolio and pipeline support the stock amidst volatile equity markets
By Sai Prabhakar Yadavalli, bl. research bureau
Sun Pharma: ACCUMULATE ON DIPS Current Market Price: ₹1,698.10
WHY
- Two recent launches in US with one more expected in one year.
- Strong India performance should benefit from generic Semaglutide launch.
- Modest premium in valuations supported by increasing innovative medicine contribution.
With two innovative medicine launches underway in the US and a third expected in the next one year along with generic Semaglutide launch in India, Sun Pharma is positioned well across geographic segments. The company has gradually strengthened its innovative portfolio, which now accounts for 25 per cent of Q3FY26 sales. This has supported an EBITDA margin expansion of 450 basis points in the last five years. With a pipeline of assets, the segment should support the improved margin profile, cash-flow prospects and pricing power, compared to Indian peers.
This is captured in the valuations at 31 times one-year forward earnings compared to Nifty Pharma or Sun Pharma’s own last five-year average at 28.5 times. In January 2025, it was recommended that investors accumulate the stock; since then, the stock has returned -4 per cent. For long-term investors, the stock can add value as a defensive stock as part of a diversified portfolio. One potential risk is from tariff announcements by the US on innovative medicine.
INNOVATIVE MEDICINE
The company has renamed its specialty segment to Global Innovative Medicines, reflecting revenues from patented medicines rather than generics. The segment, with more than $1 billion in annual revenues and a Q3FY26 exit growth rate of 13.3 per cent year on year, is now a mature, self-sustained value generator.
The leading asset, Ilumya (for plaque psoriasis), reported sales of $680 million in FY25 globally. Sun Pharma has applied for a supplemental application in Psoriatic Arthritis, with a launch expected in the next year. Two more US products launched in the last year include:
- Leqselvi (deuruxolitinib): Launched in July 2025 for severe alopecia areata.
- Unloxcyt (cosibelimab): Launched in January 2026 for advanced Cutaneous Squamous Cell Carcinoma (aCSCC), adding a checkpoint inhibitor to the portfolio.
Pipeline assets include Fibromun (in Phase-II and Phase-III trials for glioblastoma and soft tissue sarcoma) and GL0034 (in early trials for type-2 diabetes). With close to $3 billion in cash, Sun Pharma can also look for strategic acquisitions.
INDIA AND OTHERS
Sun Pharma is the industry leader in the Indian pharma market, growing faster than the industry at a 13 per cent CAGR in FY21-25. It is the leader in the diabetes segment in India and will participate in the first wave of launches for generic Semaglutide, having secured approvals for both weight loss and diabetes brands.
The Rest of the World and Emerging Markets accounted for 34 per cent of 9MFY26 revenues, reporting growth of 17–20 per cent. Ilumya has now been launched in 35 countries.
FINANCIAL OUTLOOK
Gross and EBITDA margins have expanded, benefiting from the innovative medicine mix. Revenue growth stood at 11 per cent in 9MFY26. Margin expansion may face temporary headwinds in the next year due to launch costs of approximately $100 million for two new products. Consensus estimates place revenue and earnings growth at 11 per cent and 12 per cent, respectively, in FY27.
Based on the sources provided, here is the reproduction of the article regarding the outlook for benchmark stock indices.
Short fall
INDEX OUTLOOK. The benchmark indices can dip more to test supports and reverse higher eventually
By Gurumurthy K, bl. research bureau
Nifty 50, Sensex and Nifty Bank index did not see a strong follow-through rise after opening last week on a positive note. Sensex and Nifty fell sharply towards the end of the week, giving away all their gains and closing down 1.14 per cent and 0.87 per cent, respectively. The Nifty Bank index also fell but managed to close the week marginally higher by 0.11 per cent.
On the charts, the near-term picture looks weak, and indices can fall more this week. However, supports are expected to limit the downside and act as a floor for a potential reversal higher. Positive sentiment is bolstered by Foreign Portfolio Investors (FPIs), who bought Indian equities for the second consecutive week with a net inflow of about $1.27 billion.
NIFTY 50 (25,471.10)
- Short-term view: Immediate supports are at 25,200 and 25,100. Nifty is expected to reverse higher from this zone toward 26,000–26,100 and potentially 26,400. A break below 25,100 could extend the fall to 24,700 or 24,400.
- Medium-term view: The broader picture remains bullish with strong support between 23,500 and 24,000. The index can target 27,500–28,000 in the medium term, with long-term potential for 30,000–31,000. This view would be negated only if the index falls below 23,500.
NIFTY BANK (60,186.65)
- Short-term view: The near-term picture is unclear. Key supports lie at 60,000 and the 59,750–59,550 zone. A bounce from here could lead the index back to 61,000. A breach of 61,000 is necessary to open the upside for 62,000 and higher levels.
- Medium-term view: Sideways consolidation within a broader uptrend continues. A bullish breakout above 61,000 eventually could target 63,000–63,500 initially and 68,000–69,000 in the long term. Support at 53,500 is crucial to maintain this outlook.
SENSEX (82,626.76)
- Short-term view: Supports are at 82,450 and 82,000. As long as Sensex stays above 82,000, a bounce back to 84,500–85,000 and a revisit of 86,000 is possible. A fall beyond 80,000 is not currently expected.
- Medium-term view: The broader uptrend is intact with targets of 89,000–90,000 (medium term) and 98,000–99,000 (long term). The bullish view is negated only if the index breaks the 79,500 support.
MIDCAP AND SMALLCAP OUTLOOK
- Nifty Midcap 150 (21,884.35): Near-term support is at 21,500; a bounce could reach 22,800. A break above 22,800 would clear the path for 26,000–26,500 in the medium term. Crucial supports are at 20,500 and 20,000.
- Nifty Smallcap 250 (15,988.30): Support is at 15,850. A bounce could target 16,600–16,700 in a week or two, and eventually 18,300. A break above 18,300 could take the index to 22,500–23,000 in the long term. The sources reiterate that this remains a good time to enter the small-cap segment, provided the index stays above 15,000.
IMMEDIATE SUPPORTS
- Nifty 50: 25,200, 25,100
- Sensex: 82,450, 82,000
- Nifty Bank: 59,750–59,550
Based on the sources provided, here is the reproduction of the article regarding the upcoming changes and features in EPFO 3.0.
What’s new in EPFO 3.0?
PF-WISE. The new app would enable withdrawal of proceeds from bank ATMs, and use of UPI interface.
By Venkatasubramanian K, bl. research bureau
Oftentimes, we hear many subscribers of the Employees’ Provident Fund (EPF) expressing dissatisfaction about the delay or denial of rightful claims. From portal glitches to the non-receipt of OTPs and non-updation of passbooks, the list of grievances is long.
However, change is on the horizon. The Labour Minister announced in December 2025 that a new EPFO 3.0 app would be rolled out early in 2026, with recent reports indicating it should be up and running by April 2026.
NEW APP, NEW FEATURES
EPFO 3.0 is not an upgrade but an entirely new app dedicated to EPF transactions. While the Umang app and UAN portal will continue to function for now, the new app is designed for easier navigation and more comprehensive detail capture.
Key features include:
- ATM Withdrawals: The EPFO will provide ATM cards linked to EPF accounts upon application. Approved claim funds will be released to the linked bank account and can be withdrawn from designated ATMs.
- UPI Interface: Withdrawals can also be conducted via linked UPI accounts at ATMs.
- Self-Service Transactions: Subscribers can correct information, upload KYC documents, and modify bank or personal details themselves via OTP authentication on their mobile devices.
- No Employer Intervention: Most updates and transactions will no longer require authentication from the employer.
- Faster Approvals: Claim approval timelines are expected to drop from a few weeks to just a few days.
ELIGIBILITY CRITERIA
To use these new features, subscribers must meet three criteria:
- An active UAN (Universal Account Number).
- An active mobile number linked to the UAN.
- A KYC-compliant account, which requires Aadhaar, PAN, a passport-size photograph, and bank details. Subscribers must upload scanned cheque leaves as part of this online process.
REDUCED TIMELINES & STANDARDIZATION
In October 2025, the EPFO’s central board of trustees (CBT) approved several reforms to simplify the framework.
- Merged Framework: As many as 13 types of partial withdrawal provisions have been merged into one simplified framework.
- Reduced Subscription Period: You can now make withdrawals for all purposes (medical, education, marriage, etc.) after only 12 months of contributions. Previously, these required between three and seven years depending on the purpose.
- Higher Withdrawal Limits: The withdrawal amount is now standardized at up to 75 per cent of the accumulated EPF corpus (including employer and employee contributions plus interest).
UNEMPLOYMENT BENEFITS
If a subscriber is rendered unemployed due to involuntary attrition or other reasons, they can now withdraw 75 per cent of their corpus immediately. The remaining 25 per cent can be withdrawn after one year if they remain unemployed.
PLAN WISELY
While withdrawals are easier, the Labour Ministry notes that about 75 per cent of subscribers had less than ₹50,000 at the time of final settlement. Experts advise subscribers to treat the EPF as a retirement kitty with its 8.25 per cent annual assured returns, rather than using it for every contingency. Instead, investors should maintain a separate emergency corpus and insurance for risks.
OVERVIEW
- Simple to log into
- Standardised procedures
- Higher withdrawals
Based on the source provided, there is no standalone article titled "Emerging Tech Redefining What it Takes to Scale Globally."
Instead, this phrase appears within the column "AI Will Usher a Golden Age of Dum Pukht" by Indrajit Hazra. The author mentions it as a pitch for a paper he presented to the organizers of the "AI Impact Summit" in Delhi, which was ultimately rejected for being "too niche".
Below is the reproduction of the section of that article where the author discusses this concept and what his presentation would have entailed:
From "AI Will Usher a Golden Age of Dum Pukht"
By Indrajit Hazra
Hazra describes his attempt to engage with the upcoming AI Impact Summit:
"Which is what happened to me when, earlier this week, I approached organisers of AI Impact Summit that kicks off in Delhi tomorrow. Coming from a non-tech background, my pitch for a paper on how emerging tech is redefining what it takes to scale globally was considered too niche and 'Get out of here' ridiculous".
Despite the rejection, Hazra outlines the core of the presentation he would have given to India's business leaders regarding the transition from traditional methods to an AI-driven global scale:
- The Paradigm Shift: He likens current human intelligence to "Cro-Magnons at the entrance" of a new era.
- A New Way to Scale: He describes a hypothetical speech to "fellow sentients" about how to transition a business into a global enterprise: "Earlier, how you’d scale a business into a global enterprise was to find leaders. In the generative AI sphere... OpenAI making prompting the new data, which, if you’re a member, was once the new oil. Scaling, for us and everyone else, will soon be training on AI created content".
- The Concept of "AI Dum Pukht": The article ultimately argues that while AI will handle the "supreme processing speeds" and solve problems automatically, human-created products—which he calls "Dum Pukht" (slow cooking)—will become the rare, high-value "collectibles" in a world where everything else is scaled by machines.
Based on the source provided, there is no article titled "Economy Needs to Draw on Patient Capital" or any content explicitly discussing "patient capital" within the provided page of The Economic Times.
The articles available in the provided source (dated February 15, 2026) are:
- "A Regal Cambodian Experience of Intimacy and Balance..." by Sivakumar Sundaram (a culinary review).
- "It Wanders Lonely as a Cloud That Floats..." by Atanu Biswas (an exploration of nihilism and Haruki Murakami).
- "Climbing Mt Olypbud in Calcutta’s M. Chateaubriand" by Ruchir Joshi (a restaurant review).
- "AI Will Usher a Golden Age of Dum Pukht" by Indrajit Hazra (an essay on AI scaling and the future value of human-created products).
- "FAFO Parenting" (a column on modern parenting trends).
While Indrajit Hazra’s article mentions scaling businesses and the value of "slow" human intelligence (metaphorically represented by the "Dum Pukht" cooking method), it focuses on generative AI and "Non-Artificial Intelligence" (NAI) rather than "patient capital" or broader economic investment strategies.